These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6036067)

  • 1. A colony inhibition (CI) technique for demonstration of tumor cell destruction by lymphoid cells in vitro.
    Hellström I
    Int J Cancer; 1967 Jan; 2(1):65-8. PubMed ID: 6036067
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on allogeneic inhibition. 3. Inhibition of mouse tumor cell colony formation in vitro by contact with lymphoid cells containing foreign H-2 antigens.
    Hellström KE; Hellstrôm I; Bergheden C
    Int J Cancer; 1967 Jul; 2(4):286-96. PubMed ID: 6066044
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic inhibition in vitro.
    Hellström KE; Hellström I
    Ann Med Exp Biol Fenn; 1966; 44(2):177-80. PubMed ID: 5965840
    [No Abstract]   [Full Text] [Related]  

  • 4. Demonstration of H-2 isoantigens and polyoma specific tumor antigens by measuring colony formation in vitro.
    Hellström I; Sjögren HO
    Exp Cell Res; 1965 Oct; 40(1):212-5. PubMed ID: 4284529
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytocidal effect of dimethyl sulfoxide on normal and leukemic lymphocytes.
    Schrek R; Elrod LM; Batra KV
    Ann N Y Acad Sci; 1967 Mar; 141(1):202-13. PubMed ID: 5342257
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth-inhibitory activity of lymphoid cell plasma membranes. I. Inhibition of lymphocyte and lymphoid tumor cell growth.
    Stallcup KC; Dawson A; Mescher MF
    J Cell Biol; 1984 Oct; 99(4 Pt 1):1221-6. PubMed ID: 6434546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-inhibitory activity of lymphoid cell plasma membranes. II. Partial characterization of the inhibitor.
    Stallcup KC; Burakoff SJ; Mescher MF
    J Cell Biol; 1984 Oct; 99(4 Pt 1):1227-34. PubMed ID: 6332814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: a flow cytometric study.
    Zaleskis G; Ho RL; Diegelman P; Maccubbin D; Ujházy P; Mihich E; Ehrke MJ
    Oncol Res; 1994; 6(4-5):183-94. PubMed ID: 7841541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific in vitro cytotoxicity of thymus-derived lymphocytes sensitized to alloantigens.
    Cerottini JC; Nordin AA; Brunner KT
    Nature; 1970 Dec; 228(5278):1308-9. PubMed ID: 4922690
    [No Abstract]   [Full Text] [Related]  

  • 10. The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice.
    Weinhold KJ; Goldstein LT; Wheelock EF
    J Exp Med; 1979 Mar; 149(3):732-44. PubMed ID: 311815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies of mammalian somatic cell variation. I. Detection of H-2 phenotype in cultured mouse cell lines.
    CANN HM; HERZENBERG LA
    J Exp Med; 1963 Feb; 117(2):259-65. PubMed ID: 14018308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of clonality in lymphoid proliferations.
    Weiss LM; Spagnolo DV
    Am J Pathol; 1993 Jun; 142(6):1679-82. PubMed ID: 8506940
    [No Abstract]   [Full Text] [Related]  

  • 13. Brief communication: Specific colony inhibition by human lymphoma cells on an established human lymphoma cell line.
    Drewinko B; Mavligit G; Ambus U; Pritchett C; Gutterman J; Hersh E
    J Natl Cancer Inst; 1973 Oct; 51(4):1377-8. PubMed ID: 4800357
    [No Abstract]   [Full Text] [Related]  

  • 14. Normal murine endogenous lymphoid factor(s) inhibiting lymphocyte functions. I. In vivo effect on allogeneic tumor growth.
    Fejes M; Pasqualini CD; Braun M
    Oncology; 1980; 37(2):96-100. PubMed ID: 6444707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of alloreactive T-cell lymphomas.
    Fathman CG; Weissman IL
    Nature; 1980 Jan; 283(5745):404-6. PubMed ID: 6965424
    [No Abstract]   [Full Text] [Related]  

  • 16. Destruction of lymphoid cells by activated human lymphocytes.
    Hardy DA; Ling NR; Wallin J; Aviet T
    Nature; 1970 Aug; 227(5259):723-5. PubMed ID: 5432075
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine inhibition of a murine B cell lymphoma.
    Pisetsky DS; Haughton G
    Clin Exp Immunol; 1986 Mar; 63(3):549-54. PubMed ID: 3486733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lympho-epithelial lesions induced by plasma cells in a pulmonary MALT lymphoma].
    Foulet A; Petrella T; Viard H; Jeannin L; Drouot F; Arnould L; Justrabo E; Michiels R
    Ann Pathol; 1994; 14(1):36-40. PubMed ID: 8155191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
    Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
    Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biosynthesis of pyridoxal-5'-phosphate in lymphocytes stimulated by alloantigens in vitro].
    Sergeev AV; Bykovskaia SN; Raushenbakh MO
    Vopr Med Khim; 1978; 24(2):211-5. PubMed ID: 307304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.